VelaLabs, located in Vienna, is proud to introduce the successful implementation of high resolution mass spectrometry for its use during characterization of impurities and degradants.
Recently, an in-house research project was completed, where orthogonal methods for characterization of different excipients were established. The main focus here was on Polysorbate 80 quantitation (HPLC-ELSD), characterization of its heterogeneity and degradants (HPLC-Q-TOF-MS) and analysis of fatty acid profiles (GC-MS). Depending on the molecules investigated, additional methods can also be employed e.g. capillary electrophoresis and SEC-MALLS for proteins.
Markus Roucka, Chief Business Development & Marketing Officer at VelaLabs, says, ?Out vision is delivering analytical excellence and out-of-the-box-thinking for our customers from support during early stage method development to validated batch release methods. As structural characterization of impurities and degradantsis already included in our method development strategy, the risk of unwelcome surprises during product analysis can be drastically reduced?.
For further support in the analysis of pharmaceuticals or research projects please contact our business developer Markus Roucka (m.roucka@vela-labs.at).
About VelaLabs
VelaLabs
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 50 locations worldwide. More than 2,500 highly-trained staff members work in over 1 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Tentamus Group
An der Industriebahn 5
13088 Berlin, Germany
www.tentamus.com